Roche Announces Worldwide Availability of Blood-Based Genomic Profiling Test
Liquid biopsy test identifies 70 of the most commonly mutated genes in solid tumors as well as microsatellite instability.
Read MorePosted by Melissa Mayer | Oct 28, 2018 | Lung Cancer |
Liquid biopsy test identifies 70 of the most commonly mutated genes in solid tumors as well as microsatellite instability.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Research |
Clinical data suggest the potential utility of multiplex panels capable of moving commonly requested blood tests from laboratory settings into the community for point-of-care application.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Infectious Diseases, Molecular Diagnostics, Point-of-Care |
Enables hepatitis C point-of-care molecular testing and linkage to care.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Lung Cancer |
New kit examines most relevant EGFR exons that affect therapeutic decisions for lung cancer patients.
Read MorePosted by Melissa Mayer | Oct 20, 2018 | Clinical Chemistry, Molecular Diagnostics, Storage |
Two new fully integrated, next-generation sequencing systems will help molecular diagnostic laboratories process increasing clinical test volumes and deliver more rapid insights on a broad range of diseases.
Read More